Journal article
Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization?
Abstract
OBJECTIVES: To determine whether increased expenditures to provide unrestricted access to expensive atypical antipsychotic drugs would be associated with a reduction in hospital utilization and cost by patients with schizophrenia. Secondary objectives were to determine the factors associated with length of stay (LOS) and readmission for schizophrenia sufferers.
METHODS: Retrospective chart review identified all acute hospitalizations for …
Authors
O'Reilly D; Craig D; Phillips L; Goeree R; Tarride J-E; Parfrey P
Journal
Healthcare Policy | Politiques de Santé, Vol. 3, No. 1, pp. 58–79
Publisher
Longwoods Publishing
Publication Date
August 2007
DOI
10.12927/hcpol.2007.19174
ISSN
1715-6572